Taglich Brothers Initiates Coverage of DecisionPoint Systems, Inc.

Taglich Brothers Initiates Coverage of DecisionPoint Systems, Inc.

NEW YORK, NY — (Marketwire) — 02/15/13 — Taglich Brothers, Inc. announces it has initiated coverage of . (OTCBB: DPSI).is a provider and integrator of business mobility and wireless systems. The company designs, deploys and supports mobile computing and wireless systems that enable customers to access enterprise data at various locations (i.e. the retail selling floor, warehouse loading dock or on the road making deliveries).The complete 18-page report is available at .. is a full-service br

Structured Settlement Calculator Now Available for Cash Payout Estimate on My Structured Settlement Cash

Structured Settlement Calculator Now Available for Cash Payout Estimate on My Structured Settlement Cash

My Structured Settlement Cash has made a new addition to their website. A structured settlement calculator is now available on the site, and will give users an estimate of what their structured settlement is worth. Only a few pieces of information are needed to calculate the buyout estimate, which is a good place to start before getting a no-obligations quote.

Hearst Ventures Makes Equity Investment in Science Inc.

Hearst Ventures Makes Equity Investment in Science Inc.

NEW YORK, NY — (Marketwire) — 02/15/13 — , a unit of Hearst Corporation, and today announced a minority equity investment by Hearst in Science Inc., a technology operating company specializing in the creation and rapid scaling of digital businesses. The joint announcement was made by Frank A. Bennack, Jr., CEO of Hearst Corporation; Scott Sassa, president, Hearst Entertainment & Syndication, the group that operates Hearst Ventures; and Michael Jones, CEO of Science. Financial terms of t

YaFarm Technologies Announces ISCI IRB Submission

PITTSTON, ME — (Marketwire) — 02/15/13 — YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) is pleased to announce that The Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, has submitted its complete protocols for the treatment of chronic and degenerative diseases to the Institutional Review Board (IRB) of the International Cell Surgical Society (ICSS).ISCI submitted the protocols for independent evaluation and review